Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial

Objective To determine whether the immunogenicity of a single dose infant priming schedule of serogroup C meningococcal (MenC) conjugate vaccine is non-inferior to a two dose priming schedule when followed by a booster dose at age 12 months. Design Phase IV open label randomised controlled trial car...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ
Main Authors: Pace, David, Khatami, Ameneh, McKenna, Jennifer, Campbell, Danielle, Attard-Montalto, Simon, Birks, Jacqueline, Voysey, Merryn, White, Catherine, Finn, Adam, Macloed, Emma, Faust, Saul N, Kent, Alison Louise, Heath, Paul T, Borrow, Ray, Snape, Matthew D, Pollard, Andrew J
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group Ltd. 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4382115/
https://ncbi.nlm.nih.gov/pubmed/25832102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.h1554
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados